NVS News
Novartis AG
$146.88
+$4.47(+3.14%)
53
Overall
80
Value
20
Tech
60
Quality
Market Cap
$280.27B
Volume
1.64M
52W Range
$121.57 - $170.46
Target Price
$151.30
NVS news: the latest Novartis AG headlines, press releases and market updates, newest first.
Latest NVS News
- Barclays Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
- Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)TipRanks Newsroom · Oct 5, 2026
- Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)TipRanks Newsroom · Oct 2, 2026
- Goldman Sachs Remains a Sell on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
- RBC Capital Remains a Hold on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
- Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead AssetNewswire TipRanks · Sep 25, 2026
- Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Arrowhead Pharmaceuticals (ARWR)TipRanks Newsroom · Sep 24, 2026
- HSBC Remains a Buy on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Sep 23, 2026
- Goldman Sachs Keeps Their Sell Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Sep 22, 2026
- Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)TipRanks Newsroom · Sep 21, 2026
- Novartis AG (NOVN) Receives a Hold from UBSTipRanks Auto-Generated Intelligence Newsdesk · Sep 18, 2026
- Cineverse Shareholders Approve IndiCue Acquisition Stock IssuanceTipRanks Auto-Generated Newsdesk · Sep 17, 2026
- RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Sep 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVS | $146.88 | +3.1% | 1.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |